Investors Continue to Take Profits in Arena (ARNA); Shares Down ~13% Over Last Two Sessions
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Join SI Premium – FREE
Shares of Arena Pharma (Nasdaq: ARNA) are continuing lower once again Tuesday following a nearly 5 percent decline on Monday. The stock is currently down about 8 percent to around $2.52. Notably, it appears shares may be able to hold above support at $2.50.
Arena shares surged about 85 percent during the end of March following fourth-quarter results and ahead of an FDA advisory committee meeting to discuss the cardiovascular risks of obesity drugs. Investors are likely continuing to take profits following the very sharp move higher.
Peers Orexigen (Nasdaq: OREX) and VIVUS (Nasdaq: VVUS) are not trading similarly to Arena shares this morning.
Of note over the last several trading sessions, Arena shares tested the 200-day SMA but have yet to push back over the technical indicator.
Volume appears to be heavy Tuesday. About 7.7 million shares of Arena have already traded hands, which compares to the stock's 30-day average of about 11 million shares per day.
Arena shares surged about 85 percent during the end of March following fourth-quarter results and ahead of an FDA advisory committee meeting to discuss the cardiovascular risks of obesity drugs. Investors are likely continuing to take profits following the very sharp move higher.
Peers Orexigen (Nasdaq: OREX) and VIVUS (Nasdaq: VVUS) are not trading similarly to Arena shares this morning.
Of note over the last several trading sessions, Arena shares tested the 200-day SMA but have yet to push back over the technical indicator.
Volume appears to be heavy Tuesday. About 7.7 million shares of Arena have already traded hands, which compares to the stock's 30-day average of about 11 million shares per day.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- NVIDIA (NVDA) in talks to invest in data-center company Cloverleaf Infrastructure - WSJ
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
